1. 5PSQ-072 Acute promyelocytic leukaemia after infliximab therapy in a crohn's disease patient: a case report and a review of the literature. (March 2019) Authors: Camuffo, L; Lucatelli, MV; Pieri, G; Bacci, C; Inzalaco, G; Puzziferri, R; Di Carlo, C; Fazio, M Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3PC-045 Formulation and stability study of extemporaneous oral liquid dosage forms containing flecainide acetate 2 mg/ml for paediatric use. (March 2019) Authors: Casiraghi, A; Loiacono, S; Bordignon, S; Puzziferri, R; Cilurzo, F; Minghetti, P Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 5PSQ-064 Related risk of biologic drugs for Crohn's disease in pregnancy: a case report and revision of the literature. (24th March 2020) Authors: Lucatelli, MV; Roperti, M; Bacci, C; Camuffo, L; Puzziferri, R; Pieri, G Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗